Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients

被引：0

作者：

Daphne SC Lee

Sook-Yee Yoon

Lai Meng Looi

Peter Kang

In Nee Kang

Kavitta Sivanandan

Hany Ariffin

Meow Keong Thong

Kin Fah Chin

Nur Aishah Mohd Taib

Cheng-Har Yip

Soo-Hwang Teo

机构：

[1] Sime Darby Medical Centre,Cancer Research Initiatives Foundation

[2] University Malaya Medical Centre,Department of Pathology

[3] University Malaya,Department of Paediatrics

[4] University Malaya Cancer Research Institute,Department of Surgery

[5] University Malaya Medical Centre,undefined

[6] University Malaya,undefined

[7] University Malaya Medical Centre,undefined

[8] University Malaya,undefined

[9] University Malaya Medical Centre,undefined

[10] University Malaya,undefined

来源：

Breast Cancer Research | / 14卷

关键词：

Breast Cancer; TP53 Mutation; Contralateral Breast Cancer; Germline TP53 Mutation; TP53 Mutation Carrier;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
Zhang, Yinmei
Wu, Heming
Gan, Caiyan
Rao, Hui
Wang, Qiuming
Guo, Xueming
BMC MEDICAL GENOMICS, 2024, 17 (01)
[22] BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients
Fatemeh Keshavarzi
Gholam Reza Javadi
Sirous Zeinali
Familial Cancer, 2012, 11 : 57 - 67
[23] BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
Yinmei Zhang
Heming Wu
Caiyan Gan
Hui Rao
Qiuming Wang
Xueming Guo
BMC Medical Genomics, 17
[24] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
Warner, Ellen
CANCERS, 2018, 10 (12)
[25] Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service
Matta, Bruna Palma
Gomes, Renan
Mattos, Daniel
Olicio, Renata
Nascimento, Caroline Macedo
Ferreira, Gerson Moura
Brant, Ayslan Castro
Boroni, Mariana
Furtado, Carolina
Lima, Valdirene
Martins Moreira, Miguel Angelo
Evangelista dos Santos, Anna Claudia
SCIENTIFIC REPORTS, 2022, 12 (01)
[26] BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
McAlpine, Jessica N.
Porter, Henry
Koebel, Martin
Nelson, Brad H.
Prentice, Leah M.
Kalloger, Steve E.
Senz, Janine
Milne, Katy
Ding, Jiarui
Shah, Sohrab P.
Huntsman, David G.
Gilks, C. Blake
MODERN PATHOLOGY, 2012, 25 (05) : 740 - 750
[27] Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations
Siranoush Manoukian
Bernard Peissel
Simona Frigerio
Daniele Lecis
Jirina Bartkova
Gaia Roversi
Paolo Radice
Jiri Bartek
Domenico Delia
Breast Cancer Research and Treatment, 2011, 130 : 207 - 215
[28] Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations
Manoukian, Siranoush
Peissel, Bernard
Frigerio, Simona
Lecis, Daniele
Bartkova, Jirina
Roversi, Gaia
Radice, Paolo
Bartek, Jiri
Delia, Domenico
BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) : 207 - 215
[29] BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia
Kristiina Tamboom
Krista Kaasik
Jelena Aršavskaja
Mare Tekkel
Aili Lilleorg
Peeter Padrik
Andres Metspalu
Toomas Veidebaum
Hereditary Cancer in Clinical Practice, 8
[30] Screening for BRCA1 and BRCA2 mutations in eastern Finnish breast/ovarian cancer families
Hartikainen, J. M.
Kataja, V.
Pirskanen, M.
Arffman, A.
Ristonmaa, U.
Vahteristo, P.
Ryynanen, M.
Heinonen, S.
Kosma, V-M
Mannermaa, A.
CLINICAL GENETICS, 2007, 72 (04) : 311 - 320

← 1 2 3 4 5 →